← FDA DRUG APPROVALS

FDA ANDA · ANDA075726

PEMOLINE

Sponsor: MALLINCKRODT

APPLICATION
ANDA075726
TYPE
ANDA
ORIGINAL APPROVAL
2001-03-30
LATEST ACTION
2001-03-30
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PEMOLINEDiscontinued
PEMOLINE 18.75MG · TABLET · ORAL
PEMOLINEDiscontinued
PEMOLINE 75MG · TABLET · ORAL
PEMOLINEDiscontinued
PEMOLINE 37.5MG · TABLET · ORAL

Approval history

2001-03-30OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →